No Detail Found!

Growth Failure in ?-thalassemia Major Patients Undergoing Repeated Transfusions.

Author(s)
Shazia Ali Department of Physiology Islamic International Medical College Riphah International University, Islamabad, Pakistan
Sarwat Jahan Department of Animal Sciences Faculty of Biological Sciences Quaid-i-Azam University, Islamabad, Pakistan
Abstract
Objective: To determine the effects of iron overload on Height, Body Mass Index (BMI), Hemoglobin and Serum Ferritin levels in beta thalassemia major patients undergoing regular blood transfusion. Study Design: Case control study. Place and Duration of Study: It was carried out at Quaid-e-Azam University, Islamabad in collaboration with Jamila Sultana Foundation Rawalpindi, Thalassemia House Rawalpindi and Pakistan Institute of Medical Sciences (PIMS), Islamabad from 5th January 2010 to 5th December 2014. Materials and Methods: Total 300 individuals were included in the study out of which 200 were Beta thalassemia major patients and 100 were controlled matched for age and gender with the thalassemic group. They were further divided into 4 groups of <13 years female, =13 years female, <13 years male and =13 years male (each having 50 thalassemic and 25 control). Height, BMI, Hemoglobin and serum Ferritin levels were determined. Non parametric (Spearman) co-relation co efficient was used to find the correlation between BMI and Ferritin and Hb levels. Data was analyzed through Graph Pad Prism 5.01. P<0.05 was considered statistically significant. Results: All groups had reduced Height, BMI, Hb and high Ferritin levels as compared to the control groups. Significantly positive (P<0.001) correlation of BMI with Hemoglobin and serum Ferritin levels were observed in thalassemic females of =13. While <13 years thalassemic males had significant (P<0.01) negative correlation of BMI with Hemoglobin. Conclusion: Our study revealed that beta thalassemic patients had reduced height and BMI, associated with high levels of serum ferritin and low hemoglobin.
Publication Details
Page(s) 120-125
DOI DOI not available
Published Journal: Journal of Islamic International Medical College, Volume: 11, Issue: 3, Year: 2016

Request the full text from PASTIC

References
ArgyropoulouMI,AstrakasL, 2007.MRI evaluation of tissue iron burden in patients with beta-thalassaemia major,PediatrRadiol 37 1191 -200
TaksandeA,PrabhuS,VenkateshS, 2012.,Cardiovascular Aspect of Beta-Thalassaemia. Cardiovasc Hematol Agents Med Chem 10 25 -30
RundD,RachmilewitzE, 2005.,N Engl J Med 353 1135 -46
CazzolaM,Borgna PignattiC,LocatelliF,PonchioL,BeguinY,De Stefano P., 1997.A moderate transfusion regimen may reduce iron loading in beta-thalassemia major without producing excessive expansion of erythropoiesis,Transfusion 37 135 -40
CappelliniMD, 2007.Exjade® (deferasirox, ICL670) in the treatment of chronic iron overload associated with blood transfusion,TherClin Risk Manag 3 291 -9
PiomelliS., 1995.The management of patients with Cooley's anemia: transfusions and splenectomy,SeminHematol 32 262 -8
MahanLK,Escott-StumpS,Krause's Food , Nutrition, and Diet,Therapy, 2000., 370 493 -4
Soliman , AT,AmerM,AnsariBM, 2009.Growth and pubertal development in transfusion dependent children and adolescents with thalassaemia major,Hemoglobin 33 16 -20
ChatterjeeR,BajoriaR, 2009.Osteopenia-osteoporosis syndrome in patients with thalassemia: understanding of type of bone disease and response to treatment,Hemoglobin 33 36 -8
ShanderA,CappelliniMD,GoodnoughLT, 2009.Iron overload and toxicity: the hidden risk of multiple blood transfusions,Review Vox Sang 97 185 -97
De SanctisV,RoosM,GasserT,FortiniM,RaiolaG,GalatiMC, 2006.Italian Working Group on Endocrine Complications in Non-Endocrine Diseases. Impact of long-term iron chelation therapy on growth and endocrine functions in Thalassaemia,J. Pediatr. Endocrinol. Metabol 19 471 -80
MorrisonED,BrandhagenDJ,PhatakPD,BartonJC,KrawittEL,El SeragHB, 2003.Serum ferritin level predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosis,Ann Intern Med 138 627 -33
FilesB,BrambillaD,KutlarA,MillerS,VichinskyE,WangW, 2002.Longitudinal changes in ferritin during chronic transfusion: a report from the Stroke Prevention Trial in Sickle Cell Anemia (STOP),J PediatrHematolOncol 24 244 -5
OlivieriNF,BrittenhamGM, 1997.Iron-chelating therapy and the treatment of thalassemia,Blood 89 739 -61
Najaf ipour F,AliasgarzadehA,AghamohamedzadehN,BahramiA,MobasriM,NiafarM, 2008.A cross- sectional study of metabolic and endocrine complications in betathalassemia major,Ann Saudi Med 28 361 -6
LiCK,LukCW,LingSC,ChikKW,YuenHL,LiCK, 2002.Morbidity and mortality patterns of thalassemia major patients in Hong Kong: retrospective study,Hong Kong Med 8 255 -60
De SanctisV,KatzM,VulloC,BagniB,UghiM,WonkeB, 1994.Effect of different treatment regimes of linear growth and final height in beta thalassemia major,ClinEndocrinol 40 791 -8
ArcasoyA,CavdarA,CinS,ErtenJ,BabacanE,GözdasogluS, 1987.Effects of zinc supplementation in linear growth in bthalassemia (a new approach),Am J Hematol 24 127 -36
KattamisC,LiakopoulouT,KattamisA, 1990.Growth and development in children with thalassemia major,Act Paediatr Scand 1 111 -7
Ali Akbar Asadi Pooya , Hamdollah,Karamifar, 2004.Body mass index in children with beta-thalassemia major,Turk J Haematol 21 177 -80
EissaDS, 2014.Iron overload in transfusiondependent b-thalassemia patients: defining parameters of comorbidities,Egyptian J Haematol 39 164 -70
ViprakasitV,TanphaichitrVS,MahasandanaC,AssteerawattA,SuwantolL,VeerakulG, 2001.Linear growth in homozygous beta-thalassemia and beta thalassemia/ hemoglobin E patients under different treatment regimens,J Med Assoc Thai 84 929 -41
TheodoridisC,LadisV,PapatheodorouA,BerdousiH,PalamidouF,EvagelopoulouC, 1998.Growth and management of short stature in thalassaemia major,J Pediatr Endocrinol Metab 11 835 -44
AdilA,SobaniZA,JabbarA,AwanS., 2012.Endocrine complications in patients of beta thalassemia major in a tertiary care hospital in Pakistan,J Pak Med Assoc 62 307 -10
ShalitinS,CarmiD,WeintrobN,PhillipM,MiskinH,KornreichL, 2005.Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients,Eur J Haematol 74 93 -100
Hegazi , M A M,ObadaMA, 2013.Effect of Iron Overload on Function of Endocrine Glands in Egyptian Beta Thalassemia Patients,Journal of Applied Sciences Research 9 4656 -62
Charles , A,LinkerM., 2005.Current medical treatment and diagnosis,Blood 13 482 -8
AbdulzahraMS,Al-HakeimHK,RidhaMM, 2011.Study of the effect of iron overload on the function of endocrine glands in male thalassemia patients,Asian J Transfus Sci 5 127 -31
0

Citations

0

Downloads

82

Views